Pfizer Inc. Common Stock (PFE)

About PFE

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

75,000

Website

www.pfizer.com/

Fundamentals

1-day range

$27.77$28.02

Market cap

$142.66B

P/E (trailing)

35.19

P/E (forward)

9.66

EPS (trailing)

$0.76

Dividend yield

5.38%

Beta

0.28

Avg. volume

42.39M

Ex-dividend date

July 24, 2026

Dividend pay date

September 1, 2026

Forecasts

26 analyst ratings

Pfizer Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• PFE

  Pfizer Inc. Common Stock

  $27.95

  ▼ 0.25%
  Market cap $142.66BP/E 35.19
  $23.58$28.75
• VRTX

  Vertex Pharmaceuticals Incorporated Common Stock

  $541.72

  ▼ 1.06%
  Market cap $119.47BP/E 30.70
  $374.17$555.69
• SNY

  Sanofi ADS

  $44.82

  ▼ 0.04%
  Market cap $104.75BP/E 16.24
  $71.25$91.15
• GSK

  GSK plc American Depositary Shares (Each representing two Ordinary Shares)

  $50.82

  ▲ 1.09%
  Market cap $104.31BP/E 15.53
  $1,441$2,282
• ABT

  Abbott Laboratories Common Stock

  $112.42

  ▲ 0.74%
  Market cap $185.36BP/E 35.52
  $81.97$137.49
• NVO

  Novo Nordisk A/S Common Stock

  $45.6

  ▼ 1.43%
  Market cap $208.51BP/E 11.40
  $224.25$409.95
• AZN

  AstraZeneca PLC Ordinary Shares

  $162.69

  ▼ 1.11%
  Market cap $244.97BP/E 23.44
  $10,784$15,730

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
  benzinga · 8/25/2026
• Buy 4 Barron's Better Bets (Than T-Bills) Out Of 11 'Safer' August DiviDogs
  SeekingAlpha · 8/22/2026
• This 'Dynamo' Biotech Puts AI-Fueled Breakout In Motion
  Yahoo · 8/21/2026
• Can mRNA Cure Cancer? Inside the Pipeline Risks for Biotech’s Biggest Players
  Yahoo · 8/21/2026
• Lilly's Multiple Assumes Less Growth Than You Think
  Yahoo · 8/21/2026
• 2 Reasons to Watch PFE and 1 to Stay Cautious
  Yahoo · 8/21/2026
• Most Of What Moves AbbVie Stock Has Nothing To Do With The Market
  Yahoo · 8/21/2026
• Can Eliquis Cushion Bristol Myers' Legacy Portfolio Erosion?
  Yahoo · 8/21/2026
• Form 8.3
  Yahoo · 8/21/2026

• Albert Bourla · August 12, 2026 · Buy

  38.0K @ $26.34
• Jennifer B. Damico · August 5, 2026 · Sale

  3.3K @ $25.4
• Mortimer J. Buckley · August 5, 2026 · Buy

  37.6K @ $25.52
• Ronald E. Blaylock · August 5, 2026 · Buy

  39.2K @ $25.46
• Albert Bourla · July 31, 2026 · Grant

  24 @ $25.01
• Albert Bourla · July 15, 2026 · Grant

  24 @ $24.82
• Albert Bourla · July 9, 2026 · Grant

  84 @ $24.25
• Albert Bourla · June 30, 2026 · Grant

  25 @ $24.08
• Albert Bourla · June 15, 2026 · Grant

  23 @ $26
• Jennifer B. Damico · June 9, 2026 · Sale

  2.0K @ $25.7
• Albert Bourla · May 29, 2026 · Grant

  23 @ $26.18
• Albert Bourla · May 15, 2026 · Grant

  24 @ $25.33
• Albert Bourla · April 30, 2026 · Grant

  22 @ $26.7
• Mortimer J. Buckley · April 23, 2026 · Grant

  7.7K @ $26.67
• LITTMAN DAN R. · April 23, 2026 · Grant

  7.7K @ $26.67

Institutional Ownership

March 31, 2026

Total shares held

3.72B

Total value held

$100.55B

Institutional holders

2920